A Combined Phase 2/3 12-week, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy of AMT-101 in Subjects With Chronic Antibiotic-resistant Pouchitis

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 23 May 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

03 Mar 2023 Additional data results presented in an Applied Molecular Transport media release.
03 Mar 2023 According to an Applied Molecular Transport media release, additional data results of this study presented at the European Crohn's and Colitis Organisation (ECCO) '23 Congress.
22 Dec 2022 According to an Applied Molecular Transport media release, additional data will be presented at the European Crohn's and Colitis Organisation meeting in March 2023.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com